Blindness Cure on the Anvil After Gene Discovery

London, Oct 8 (ANI): A gene called, SERPING1, has been identified to play a major role in age-related macular degeneration (AMD), the most common cause of blindness in developed countries.

The finding may hold out the prospect of better treatments and perhaps eventually a cure, the researchers said.

Glaucoma - Causes, Symptoms, Diagnosis, Treatment & Prevention
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in intraocular pressure. Uncontrolled glaucoma can lead to blindness.

Estimates suggest that nearly two-thirds of people aged 80 years or older are affected by AMD to some degree, with more than one in ten left blind by the disease.

Earlier, scientists identified a number of other genes or genetic loci (regions of the genome), which affect a person's susceptibility to the disease.

And now, researchers at the University of Southampton have shown that a particular variant of the gene SERPING1, carried by just under a quarter of the population, may provide protection against the disease.

Council Warns Fake Vodka may Cause Blindness
South Tyneside Council's environmental health department has warned that drinking counterfeit Imperial Vodka on sale in shops in Northumberland and London could lead to blindness.

In collaboration with the team from the University of Iowa, the researchers found evidence of proteins expressed by SERPING1 in the retina and the choroid layer (the vascular layer next to the retina), the two areas affected by AMD.

The proteins are found to partly regulate the body's innate immune system known as the complement system.

National Programme for Control of Blindness Continues With Cabinet Approval
The Cabinet Committee on Economic Affairs (CCEA) today gave its approval for continuation of National Programme for Control of Blindness during 11th five

The researchers deduced that the complement system is malfunctioning, attacking the retina and choroid layer.

"It seems counterintuitive that a generalised innate immunity defence system should result in a localised disease of the eye in the elderly," the Lancet quoted Professor Andrew Lotery from the University of Southampton, corresponding author on the study, as saying.

National Eye Institute Targets Mexican-Americans for Glaucoma Awareness
NIH's National Eye Institute is seeking to raise glaucoma awareness among Mexican-Americans, who have a higher risk for the disease than others

He added: "However, it is becoming increasingly clear from research that this is the case. Previous AMD genes have already implicated the "alternate" complement pathway, and our paper shows that the 'classical' complement pathway is also involved in this process."

The research is published in the latest issue of the Lancet.

Source-ANI
RAS/L